Skip to main content

Table 1 Antisense gapmer oligonucleotides that exclusively demonstrate reverse complementarity to multiple cDNAs related to particular disorders. All nucleotides are linked by phosphorothioate linkages *, and conformationally restricted nucleotide monomers, such as tricycle-DNA, LNAs and MOEs, are preceded by +. Additional sequences can be found in Table S1 and will be updated at www.wikisequences.org

From: Identification of sequences common to more than one therapeutic target to treat complex diseases: simulating the high variance in sequence interactivity evolved to modulate robust phenotypes

Antisense oligonucleotides Targets
  Cancer
+T*+T*+G*A*T*G*G*G*G*A*A*C*T*+T*+G*+G ABL1,BLK,FGR,HCK.
+G*+C*+C*A*A*G*C*C*A*A*A*+G*+T*+C ACVR2B,ARAF,CHECK1,FGR.
+A*+G*+G*T*C*C*A*G*T*T*T*+C*+T*+G ATR,MKI67,PNK3.
+T*+G*+T*C*A*G*C*T*G*T*C*+A*+T*+T BCL2,HIF2,PSMA6.
+T*+T*+G*G*T*T*T*C*C*T*T*+T*+G*+C BIRC5,HK2,USP34.
+G*+G*+C*C*A*G*G*C*C*A*A*A*+G*+T*+C CAMK2A,CDK4,CDK16,FIP1L1,
  HCK,IRAK1,PDGFRA.
+A*+C*+C*A*G*C*T*G*C*T*T*G*+A*+A*+G CCNE2,FGR1,FGR3,FGR4.
+G*+G*+C*C*A*G*G*C*C*A*A*A*G*+T*+C*+A CDK4,CDK16,FIP1L1,HCK,MAPK(1&9).
+G*+C*+C*A*T*C*C*A*C*T*T*+C*+A*+C C-KIT,C-MET,CSF1R,FGFR1,FGFR3,
  FGFR4,FIP1L1,MST1R,PDGFRA.
+T*+T*+G*C*G*G*G*C*A*G*C*C*+A*+G*+G CSK,EPHB2,FGR3,FGR4,TNK2,RIPK4.
+G*+T*+T*A*C*A*A*G*C*A*T*+C*+A*+T DOCK7,TGFB2,USP14.
+A*+G*+C*C*A*C*T*G*G*A*T*+G*+T*+G E2F1,FGR1,FGR3,FGR4,HSPA12A.
+T*+G*+T*G*A*T*A*C*T*T*T*+C*+T*+G EBAG9,MCL1,PTGS2,TMED7-TICAM2.
+A*+C*+A*T*C*A*C*T*C*T*G*G*T*G*+G*+G*+T EGFR,FGFR1,HER2.
+C*+A*+C*C*T*G*G*T*A*G*G*C*+G*+C*+A FGFR1,FGFR4,TERT.
+T*+C*+A*C*T*G*T*A*C*A*C*+C*+T*+T FGR1,FGR3,GRB7.
+C*+A*+C*C*T*G*G*T*A*G*G*C*+G*+C*+A FGR1,FGR4,TERT.
  Immunological diseases
+C*+C*+A*A*C*C*T*T*C*A*+C*+A*+C CARD9,IL7R,RPL5.
+T*+C*+T*C*C*T*T*C*C*T*C*T*G*+C*+T*+T KRT17,NLRP1.
+C*+C*+G*T*G*G*G*T*C*C*C*T*G*+G*+C*+A ILR6,TLR9.